Table 1.
Gene | Alias | Location | DNA methylation | Reference |
---|---|---|---|---|
PAD2 | Peptidyl arginine deiminase 2 | 1p36.13 | No difference | Mastronardi et al., 2007 |
ATP13A2 | PARK9 | 1p36.13 | No difference | Behrens et al., 2010 |
DJ-1 | PARK7 | 1p36.23 | No methylation | Tan Y. et al., 2016 |
NPAS2 | Neuronal PAS2 | 2q11.2 | Hypomethylation | Lin et al., 2012 |
UCHL1 | Ubiquitin C-terminal hydrolase L1 | 4p13 | No difference | Barrachina and Ferrer, 2009 |
PGC1-α | Peroxisome proliferator-activated receptor gamma coactivator 1-alpha | 4p15.2 | Hypermethylation | Su et al., 2015 |
TNF-α | Tumor necrosis factor-alpha | 6p21.33 | No difference | Pieper et al., 2008 |
PARK2 | Parkinson juvenile disease protein 2, Parkin | 6q26 | No difference | Cai et al., 2011 |
No difference | De Mena et al., 2013 | |||
CYP2E1 | Cytochrome P450-J | 10q26.3 | Hypomethylation | Kaut et al., 2012 |
NOS2 | Nitric oxide synthase 2 | 17q11.2 | Hypomethylation | Searles Nielsen et al., 2015 |
MAPT | Microtubule associated protein Tau | 17q21.31 | Differential methylation | Coupland et al., 2014 |
FANCC/TNKS2 | Fanconi anemia group C protein/tankyrase 2 | 9q22.32/10q23.32 | Differential methylation | Moore et al., 2014 |
PARK16/GPNMB/STX1B | PARK16/glycoprotein Nmb/syntaxin 1B | 1q32/7p15.3/16p11.2 | Differential methylation | International Parkinson’s Disease Genomics Consortium [IPDGC], and Wellcome Trust Case Control Consortium 2 [WTCCC2] |
Genome-wide | Top 30 differentially methylated genes: KCTD5, VAV2, MOG, TRI M10, HLA-DQA1, ARHGEF10, GFPT 2, HLA-DRB5, TMEM9, MRI 1, MAPT, HLA-DRB6, LASS3, GSTTP 2, GSTTP. DNAJA3, JAKMIP 3, FRK, LRR C27, DMBX1, LGALS7, FOXK1, APBA1, MAGI2, SLC25A24, GSTT 1, MYOM2, MIR886, TUBA3E, TMCO3 | Hypermethylation Hypomethylation | Masliah et al., 2013 |
From left to right: Listed are genes, gene aliases, genomic locations (according to the latest GRCh38/hg38 assembly of the human genome available at the UCSC genome browser), DNA methylation status in PD and references.